Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Barnet Dulaney Perkins Eye Centers

Status: Enrolling

Conditions: Open-Angle Glaucoma

Treatments: Procedure: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Study type: Observational

Funder types: NETWORK; Industry

Identifiers

NCT06953349

Alcon - IIT Proposal 95537309

Details and patient eligibility

About

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Full description

The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
• have Glaucoma

Exclusion criteria

• Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
• Patients with refractory CME or CME persisting 3 months or more post-operatively
• Patients with incomplete IOP, medication logs or VF data within post-operative period
• Prior incisional surgery or MIGS

Trial design

300 participants in 1 patient group

Single Group/Cohort retrospectively utilized

Description:

This will be 300 eyes that have undergone the combination of Phacoemulsification, OMNI Canaloplasty and Hydrus microstent that will successfully lower IOP in ethnically-diverse patients with Open Angle Glaucoma

Treatment:

Procedure: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis